150 related articles for article (PubMed ID: 33772241)
1. Conjunctival melanoma: outcomes based on tumour origin in 629 patients at a single ocular oncology centre.
Pacheco RR; Yaghy A; Dalvin LA; Vaidya S; Perez AL; Lally SE; Shields JA; Shields CL
Eye (Lond); 2022 Mar; 36(3):603-611. PubMed ID: 33772241
[TBL] [Abstract][Full Text] [Related]
2. Conjunctival melanoma: outcomes based on tumor origin in 382 consecutive cases.
Shields CL; Markowitz JS; Belinsky I; Schwartzstein H; George NS; Lally SE; Mashayekhi A; Shields JA
Ophthalmology; 2011 Feb; 118(2):389-95.e1-2. PubMed ID: 20723990
[TBL] [Abstract][Full Text] [Related]
3. Conjunctival Melanoma: Outcomes based on the American Joint Committee on Cancer Clinical Classification (8th Edition) of 425 Patients at a Single Ocular Oncology Center.
Shields CL; Yaghy A; Dalvin LA; Vaidya S; Pacheco RR; Perez AL; Lally SE; Shields JA
Asia Pac J Ophthalmol (Phila); 2020 Dec; 10(2):146-151. PubMed ID: 33306519
[TBL] [Abstract][Full Text] [Related]
4. Conjunctival Melanoma: Outcomes Based on Age at Presentation in 629 Patients at a Single Ocular Oncology Center.
Dalvin LA; Yaghy A; Vaidya S; Pacheco RR; Perez AL; Lally SE; Shields JA; Shields CL
Cornea; 2021 May; 40(5):554-563. PubMed ID: 32740010
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting recurrence and metastasis in conjunctival melanoma.
Çalış Karanfil F; Gündüz AK; Gündüz ÖÖ; Özalp Ateş FS
Int Ophthalmol; 2023 Nov; 43(11):4203-4215. PubMed ID: 37639080
[TBL] [Abstract][Full Text] [Related]
6. American Joint Committee on Cancer (AJCC) clinical classification predicts conjunctival melanoma outcomes.
Shields CL; Kaliki S; Al-Dahmash SA; Lally SE; Shields JA
Ophthalmic Plast Reconstr Surg; 2012; 28(5):313-23. PubMed ID: 22965011
[TBL] [Abstract][Full Text] [Related]
7. Conjunctival melanoma: Insights into classification, outcomes, and biomarkers.
Shields CL; Silva AMV; Laiton A; Kalafatis NE; Schiller E; Lally SE; Grant-Kels JM; Shields JA
Clin Dermatol; 2024; 42(1):46-55. PubMed ID: 37858779
[TBL] [Abstract][Full Text] [Related]
8. Conjunctival Melanoma: Features and Outcomes Based on the Fitzpatrick Skin Type in 540 Patients at a Single Ocular Oncology Center.
Shields CL; Yaghy A; Dalvin LA; Vaidya S; Pacheco RR; Perez AL; Ramesh S; George K; Arias DE; Shiuey EJ; Lally SE; Shields JA
Ophthalmic Plast Reconstr Surg; 2020; 36(5):490-496. PubMed ID: 32134771
[TBL] [Abstract][Full Text] [Related]
9. Primary acquired melanosis of the conjunctiva: risks for progression to melanoma in 311 eyes. The 2006 Lorenz E. Zimmerman lecture.
Shields JA; Shields CL; Mashayekhi A; Marr BP; Benavides R; Thangappan A; Phan L; Eagle RC
Ophthalmology; 2008 Mar; 115(3):511-519.e2. PubMed ID: 17884168
[TBL] [Abstract][Full Text] [Related]
10. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
Shields CL; Shields JA; Gündüz K; Cater J; Mercado GV; Gross N; Lally B
Arch Ophthalmol; 2000 Nov; 118(11):1497-507. PubMed ID: 11074806
[TBL] [Abstract][Full Text] [Related]
11. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
Shields CL
Trans Am Ophthalmol Soc; 2000; 98():471-92. PubMed ID: 11190037
[TBL] [Abstract][Full Text] [Related]
12. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
Larsen AC
Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
[TBL] [Abstract][Full Text] [Related]
13. [Differential diagnosis and management of melanocytic lesions of the ocular surface].
Tóth G; Szalai E; Csákány B; Hécz R; Sándor GL; Lukáts O; Nagy ZZ; Szentmáry N
Orv Hetil; 2020 Apr; 161(15):563-574. PubMed ID: 32320191
[TBL] [Abstract][Full Text] [Related]
14. [Malignant conjunctival melanoma. Clinical review with recommendations for diagnosis, therapy and follow-up].
Lommatzsch PK; Werschnik C
Klin Monbl Augenheilkd; 2002 Oct; 219(10):710-21. PubMed ID: 12447715
[TBL] [Abstract][Full Text] [Related]
15. PRAME Expression in Junctional Melanocytic Proliferations of the Conjunctiva: A Potential Biomarker for Primary Acquired Melanosis/Conjunctival Melanocytic Intraepithelial Lesions.
Huang YY; Hrycaj SM; Chan MP; Stagner AM; Patel RM; Bresler SC
Am J Dermatopathol; 2022 Oct; 44(10):734-740. PubMed ID: 35475786
[TBL] [Abstract][Full Text] [Related]
16. Management of pigmented conjunctival lesions.
Oellers P; Karp CL
Ocul Surf; 2012 Oct; 10(4):251-63. PubMed ID: 23084146
[TBL] [Abstract][Full Text] [Related]
17. Conjunctival Melanoma in Asian Indians: A Study of 42 Patients.
Kaliki S; Vasanthapuram VH; Mishra DK
Semin Ophthalmol; 2019; 34(3):182-187. PubMed ID: 31135259
[No Abstract] [Full Text] [Related]
18. BRAF mutations in conjunctival melanoma: investigation of incidence, clinicopathological features, prognosis and paired premalignant lesions.
Larsen AC; Dahl C; Dahmcke CM; Lade-Keller J; Siersma VD; Toft PB; Coupland SE; Prause JU; Guldberg P; Heegaard S
Acta Ophthalmol; 2016 Aug; 94(5):463-70. PubMed ID: 27009410
[TBL] [Abstract][Full Text] [Related]
19. A retrospective review of conjunctival melanoma: Presentation, treatment and evolution.
Pacheco GE; Garcia-Onrubia L; Garcia-Alvarez C; Muñoz MF; Garcia-Lagarto E; Perez DM; Alonso P; Saornil MA
Arch Soc Esp Oftalmol (Engl Ed); 2019 May; 94(5):218-224. PubMed ID: 30846247
[TBL] [Abstract][Full Text] [Related]
20. Conjunctival melanoma treatment outcomes in 288 patients: a multicentre international data-sharing study.
Jain P; Finger PT; Fili M; Damato B; Coupland SE; Heimann H; Kenawy N; J Brouwer N; Marinkovic M; Van Duinen SG; Caujolle JP; Maschi C; Seregard S; Pelayes D; Folgar M; Yousef YA; Krema H; Gallie B; Calle-Vasquez A;
Br J Ophthalmol; 2021 Oct; 105(10):1358-1364. PubMed ID: 32892167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
